282 related articles for article (PubMed ID: 23740534)
1. Treatment of infantile spasms.
Hancock EC; Osborne JP; Edwards SW
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001770. PubMed ID: 23740534
[TBL] [Abstract][Full Text] [Related]
2. Treatment of infantile spasms.
Hancock EC; Osborne JP; Edwards SW
Cochrane Database Syst Rev; 2008 Oct; (4):CD001770. PubMed ID: 18843624
[TBL] [Abstract][Full Text] [Related]
3. Treatment of infantile spasms.
Hancock E; Osborne J; Milner P
Cochrane Database Syst Rev; 2003; (3):CD001770. PubMed ID: 12917912
[TBL] [Abstract][Full Text] [Related]
4. Treatment of infantile spasms.
Hancock E; Osborne JP; Milner P
Cochrane Database Syst Rev; 2002; (2):CD001770. PubMed ID: 12076419
[TBL] [Abstract][Full Text] [Related]
5. The treatment of West syndrome: a Cochrane review of the literature to December 2000.
Hancock E; Osborne JP; Milner P
Brain Dev; 2001 Nov; 23(7):624-34. PubMed ID: 11701267
[TBL] [Abstract][Full Text] [Related]
6. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.
O'Callaghan FJ; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
Lancet Neurol; 2017 Jan; 16(1):33-42. PubMed ID: 27838190
[TBL] [Abstract][Full Text] [Related]
7. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
[TBL] [Abstract][Full Text] [Related]
8. Prednisolone or tetracosactide depot for infantile epileptic spasms syndrome? A prospective analysis of data embedded within two randomised controlled trials.
Osborne JP; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick A; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; O'Callaghan FK
Eur J Paediatr Neurol; 2023 Jan; 42():110-116. PubMed ID: 36621063
[TBL] [Abstract][Full Text] [Related]
9. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial.
Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP
Lancet; 2004 Nov 13-19; 364(9447):1773-8. PubMed ID: 15541450
[TBL] [Abstract][Full Text] [Related]
10. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.
Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
Lancet Neurol; 2005 Nov; 4(11):712-7. PubMed ID: 16239177
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of West syndrome].
Cvitanović-Sojat L; Gjergja R; Sabol Z; Hajnzić TF; Sojat T
Acta Med Croatica; 2005; 59(1):19-29. PubMed ID: 15813352
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial.
Darke K; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Lux AL; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
Arch Dis Child; 2010 May; 95(5):382-6. PubMed ID: 20457702
[TBL] [Abstract][Full Text] [Related]
14. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.
Mackay MT; Weiss SK; Adams-Webber T; Ashwal S; Stephens D; Ballaban-Gill K; Baram TZ; Duchowny M; Hirtz D; Pellock JM; Shields WD; Shinnar S; Wyllie E; Snead OC; ;
Neurology; 2004 May; 62(10):1668-81. PubMed ID: 15159460
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Lennox-Gastaut syndrome.
Hancock EC; Cross JH
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD003277. PubMed ID: 23450537
[TBL] [Abstract][Full Text] [Related]
16. Vigabatrin and high-dose prednisolone therapy for patients with West syndrome.
Ko A; Youn SE; Chung HJ; Kim SH; Lee JS; Kim HD; Kang HC
Epilepsy Res; 2018 Sep; 145():127-133. PubMed ID: 29966811
[TBL] [Abstract][Full Text] [Related]
17. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms.
Askalan R; Mackay M; Brian J; Otsubo H; McDermott C; Bryson S; Boyd J; Snead C; Roberts W; Weiss S
J Child Neurol; 2003 Mar; 18(3):165-70. PubMed ID: 12731640
[TBL] [Abstract][Full Text] [Related]
18. A risk-benefit assessment of treatments for infantile spasms.
Nabbout R
Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
[TBL] [Abstract][Full Text] [Related]
19. Treatment with High-Dose Prednisolone in Vigabatrin-Refractory Infantile Spasms.
Al-Shehhi W; Chau V; Boyd J; Snead C; Sharma R; Donner E; Go C; Jain P
Can J Neurol Sci; 2022 Jul; 49(4):532-539. PubMed ID: 34212837
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
Go CY; Mackay MT; Weiss SK; Stephens D; Adams-Webber T; Ashwal S; Snead OC; ;
Neurology; 2012 Jun; 78(24):1974-80. PubMed ID: 22689735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]